Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age

NCT06975878 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

1092

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumococcal Immunization
Healthy Volunteers

Interventions

BIOLOGICAL: PCV21 vaccine
BIOLOGICAL: Vaxneuvance vaccine
BIOLOGICAL: Hexyon vaccine
BIOLOGICAL: M-M-RvaxPro vaccine
BIOLOGICAL: Varivax vaccine

Sponsor

Sanofi